Home › Head and Neck Squamous Cell Carcinoma › Montana › Missoula
Head and Neck Squamous Cell Carcinoma clinical trials in Missoula, MT
5 studies for Head and Neck Squamous Cell Carcinoma are looking for participants at sites in and around Missoula (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
RecruitingPhase 3
- Community Medical Center, Missoula
Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
RecruitingPhase 3
- Community Medical Center, Missoula
BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
RecruitingPhase 2
- Community Medical Center, Missoula
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
RecruitingPhase 2
- Community Medical Center, Missoula
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
RecruitingPhase 2
- Saint Patrick Hospital - Community Hospital, Missoula
- Community Medical Center, Missoula
Head and Neck Squamous Cell Carcinoma trials in other cities
- Houston, TX47 studies
- Los Angeles, CA42 studies
- Boston, MA40 studies
- Nashville, TN39 studies
- New York City, NY39 studies
- St. Louis, MO28 studies
- Arlington, VA26 studies
- Chicago, IL26 studies
- Philadelphia, PA26 studies
- Atlanta, GA24 studies
- San Antonio, TX22 studies
- Pittsburgh, PA22 studies
Other studies in Missoula
- Prostate Cancer9 studies
- Non-Small Cell Lung Cancer9 studies
- Lung Cancer8 studies
- Acute Myeloid Leukemia7 studies
- Obesity5 studies
- Breast Cancer5 studies
- Melanoma5 studies
- Bladder Cancer4 studies
- Overweight4 studies
- Colon Cancer4 studies
- Colorectal Cancer4 studies
- Multiple Myeloma3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.